Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 27, Issue suppl_5, Pages v38-v49
Publisher
Oxford University Press (OUP)
Online
2017-02-04
DOI
10.1093/annonc/mdw350
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Decreased Morbidity of Laparoscopic Distal Gastrectomy Compared With Open Distal Gastrectomy for Stage I Gastric Cancer
- (2016) Wook Kim et al. ANNALS OF SURGERY
- Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
- (2016) Kei Muro et al. LANCET ONCOLOGY
- Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial
- (2016) Kazumasa Fujitani et al. LANCET ONCOLOGY
- The Proportion of Signet Ring Cell Component in Patients with Localized Gastric Adenocarcinoma Correlates with the Degree of Response to Pre-Operative Chemoradiation
- (2016) Nikolaos Charalampakis et al. ONCOLOGY
- Comparison of outcomes after laparoscopy-assisted and open total gastrectomy for early gastric cancer
- (2015) J. H. Lee et al. BRITISH JOURNAL OF SURGERY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
- (2015) Pedro Pimentel-Nunes et al. ENDOSCOPY
- Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory
- (2015) Melina Arnold et al. EUROPEAN JOURNAL OF CANCER
- Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference
- (2015) Gian Luca Baiocchi et al. Gastric Cancer
- Comparison of laparoscopic versus open gastrectomy for advanced gastric cancer: an updated meta-analysis
- (2015) Yingjun Quan et al. Gastric Cancer
- Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium
- (2015) Manish A. Shah et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses
- (2015) Se Hoon Park et al. JOURNAL OF CLINICAL ONCOLOGY
- Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germlineCDH1mutation carriers
- (2015) Rachel S van der Post et al. JOURNAL OF MEDICAL GENETICS
- Krukenberg Tumors of Gastric Origin: The Rationale of Surgical Resection and Perioperative Treatments in a Multicenter Western Experience
- (2015) Fausto Rosa et al. WORLD JOURNAL OF SURGERY
- Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study
- (2014) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Is Preoperative Chemotherapy Followed by Surgery the Appropriate Treatment for Signet Ring Cell Containing Adenocarcinomas of the Esophagogastric Junction and Stomach?
- (2014) Ulrike Heger et al. ANNALS OF SURGICAL ONCOLOGY
- Consensus guidelines for enhanced recovery after gastrectomy
- (2014) K. Mortensen et al. BRITISH JOURNAL OF SURGERY
- Phase II trial of miniDOX (reduced dose docetaxel–oxaliplatin–capecitabine) in “suboptimal” patients with advanced gastric cancer (AGC). TTD 08-02
- (2014) F. Rivera et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Prospective, Randomized, Multicenter, Phase III Study of Fluorouracil, Leucovorin, and Irinotecan Versus Epirubicin, Cisplatin, and Capecitabine in Advanced Gastric Adenocarcinoma: A French Intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) Study
- (2014) Rosine Guimbaud et al. JOURNAL OF CLINICAL ONCOLOGY
- Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial
- (2014) Akira Tsuburaya et al. LANCET ONCOLOGY
- Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
- (2014) Sung Hoon Noh et al. LANCET ONCOLOGY
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- IMRT limits nephrotoxicity after chemoradiotherapy for gastric cancer
- (2014) Anouk Kirsten Trip et al. RADIOTHERAPY AND ONCOLOGY
- A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma†
- (2013) A. C. Roy et al. ANNALS OF ONCOLOGY
- Vitamin B12 Deficiency After Gastrectomy for Gastric Cancer
- (2013) Yanfeng Hu et al. ANNALS OF SURGERY
- The Prognostic Significance of an R1 Resection in Gastric Cancer Patients Treated with Adjuvant Chemoradiotherapy
- (2013) Jurriën Stiekema et al. ANNALS OF SURGICAL ONCOLOGY
- Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer
- (2013) M. Degiuli et al. BRITISH JOURNAL OF SURGERY
- Follow-Up: The Evidence
- (2013) Domenico D'Ugo et al. DIGESTIVE SURGERY
- Randomized, Open-Label, Phase III Study Comparing Irinotecan With Paclitaxel in Patients With Advanced Gastric Cancer Without Severe Peritoneal Metastasis After Failure of Prior Combination Chemotherapy Using Fluoropyrimidine Plus Platinum: WJOG 4007 Trial
- (2013) Shuichi Hironaka et al. JOURNAL OF CLINICAL ONCOLOGY
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
- (2013) Florian Lordick et al. LANCET ONCOLOGY
- Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
- (2013) Hugo E R Ford et al. LANCET ONCOLOGY
- Differences in outcomes of oesophageal and gastric cancer surgery across Europe
- (2012) J. L. Dikken et al. BRITISH JOURNAL OF SURGERY
- A Phase II Study of Capecitabine plus Oxaliplatin as First-Line Chemotherapy in Elderly Patients with Advanced Gastric Cancer
- (2012) Xiao Jun Xiang et al. CHEMOTHERAPY
- The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: A randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+)
- (2012) Salah-Eddin Al-Batran et al. EUROPEAN JOURNAL OF CANCER
- Outcomes and prognostic factors of survival after pulmonary resection for metastatic gastric cancer
- (2012) Satoshi Shiono et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases
- (2012) Vincenzo Catalano et al. Gastric Cancer
- Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone
- (2012) Jung Hun Kang et al. JOURNAL OF CLINICAL ONCOLOGY
- Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection
- (2012) Stephen R. Smalley et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
- (2012) Yung-Jue Bang et al. LANCET
- A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection
- (2012) Wei-guo Zhu et al. RADIOTHERAPY AND ONCOLOGY
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial
- (2011) Xiao-Jun Yang et al. ANNALS OF SURGICAL ONCOLOGY
- Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer – A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
- (2011) Peter C. Thuss-Patience et al. EUROPEAN JOURNAL OF CANCER
- Japanese gastric cancer treatment guidelines 2010 (ver. 3)
- (2011) Gastric Cancer
- Guidelines for the management of oesophageal and gastric cancer
- (2011) W. H. Allum et al. GUT
- Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
- (2011) Mitsuru Sasako et al. JOURNAL OF CLINICAL ONCOLOGY
- Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
- (2011) Marc Ychou et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial
- (2011) Jeeyun Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy
- (2010) Olivier Glehen et al. ANNALS OF SURGICAL ONCOLOGY
- Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer
- (2010) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of the Extent of Surgery and Postoperative Chemoradiotherapy on Recurrence Patterns in Gastric Cancer
- (2010) Johan L. Dikken et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954
- (2010) Christoph Schuhmacher et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
- (2010) Ilfet Songun et al. LANCET ONCOLOGY
- Rechallenge with Platinum plus Fluoropyrimidine +/– Epirubicin in Patients with Oesophagogastric Cancer
- (2010) A.F.C. Okines et al. ONCOLOGY
- Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer
- (2009) A. F. C. Okines et al. ANNALS OF ONCOLOGY
- Imaging in assessing lymph node status in gastric cancer
- (2009) Robert Michael Kwee et al. Gastric Cancer
- Thromboembolism in Patients With Advanced Gastroesophageal Cancer Treated With Anthracycline, Platinum, and Fluoropyrimidine Combination Chemotherapy: A Report From the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group
- (2009) Naureen Starling et al. JOURNAL OF CLINICAL ONCOLOGY
- Gastric cancer staging at isotropic MDCT including coronal and sagittal MPR images: endoscopically diagnosed early vs. advanced gastric cancer
- (2008) Yoo Na Kim et al. ABDOMINAL IMAGING
- Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction
- (2008) M. Dank et al. ANNALS OF ONCOLOGY
- Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie
- (2008) S.-E. Al-Batran et al. ANNALS OF ONCOLOGY
- Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial
- (2008) E M L Verschuur et al. BRITISH JOURNAL OF CANCER
- A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer
- (2008) J-L Lee et al. BRITISH JOURNAL OF CANCER
- Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
- (2008) David Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Short-term changes in bone and mineral metabolism following gastrectomy in gastric cancer patients
- (2007) Ki Hyun Baek et al. BONE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started